Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Andrew Blauvelt, Jacob Pontoppidan Thyssen, Emma Guttman‐Yassky, Thomas R.M. Bieber, Esther Serra‐Baldrich, Eric Lawrence Simpson and 10 more
- Rank
- 2 of 545
- Percentile
- top 0.4%
- Where
- British Journal of Dermatology, 2023
- Citations
- 165
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.